company background image
524075 logo

Albert David BSE:524075 Stock Report

Last Price

₹1.21k

Market Cap

₹6.9b

7D

4.9%

1Y

-13.3%

Updated

06 Feb, 2025

Data

Company Financials

Albert David Limited

BSE:524075 Stock Report

Market Cap: ₹6.9b

524075 Stock Overview

Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. More details

524075 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Price-To-Earnings ratio (10x) is below the Indian market (29.3x)

Earnings have grown 29.8% per year over the past 5 years

Risk Analysis

High level of non-cash earnings

Dividend of 0.95% is not well covered by free cash flows

Does not have a meaningful market cap (₹7B)


My Notes

Capture your thoughts, links and company narrative

Albert David Limited Competitors

Wanbury

BSE:524212

₹8.0b

Medico Remedies

BSE:540937

₹6.5b

Ind-Swift Laboratories

NSEI:INDSWFTLAB

₹6.2b

Sakar Healthcare

NSEI:SAKAR

₹6.1b

Price History & Performance

Summary of share price highs, lows and changes for Albert David
Historical stock prices
Current Share Price₹1,207.05
52 Week High₹1,752.95
52 Week Low₹1,010.00
Beta0.47
1 Month Change-11.06%
3 Month Change-12.04%
1 Year Change-13.34%
3 Year Change84.24%
5 Year Change137.73%
Change since IPO8,460.64%

Recent News & Updates

Recent updates

Shareholder Returns

524075IN PharmaceuticalsIN Market
7D4.9%3.4%1.6%
1Y-13.3%19.3%5.5%

Return vs Industry: 524075 underperformed the Indian Pharmaceuticals industry which returned 18.4% over the past year.

Return vs Market: 524075 underperformed the Indian Market which returned 5.8% over the past year.

Price Volatility

Is 524075's price volatile compared to industry and market?
524075 volatility
524075 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 524075 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 524075's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19381,497Umesh Kuntewww.albertdavidindia.com

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries.

Albert David Limited Fundamentals Summary

How do Albert David's earnings and revenue compare to its market cap?
524075 fundamental statistics
Market cap₹6.89b
Earnings (TTM)₹685.47m
Revenue (TTM)₹3.65b

10.0x

P/E Ratio

1.9x

P/S Ratio

Is 524075 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524075 income statement (TTM)
Revenue₹3.65b
Cost of Revenue₹1.23b
Gross Profit₹2.42b
Other Expenses₹1.73b
Earnings₹685.47m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)120.11
Gross Margin66.22%
Net Profit Margin18.77%
Debt/Equity Ratio0.6%

How did 524075 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

9%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 10:36
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Albert David Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research